About 454
News
Find a list of 454 Life Sciences™'s press releases below:
Current | 2006 | 2005 | 2004 | 2003 | 2002
This part of our web site contains archival information, which should not be considered current and may no longer be accurate.
- 11/18/2003
454 Life Sciences Announces Publication Describing Proprietary Technology for Massively Parallel DNA Amplificatio
Enabling technology for miniaturized DNA amplification is described in the journal Electrophoresis. - 9/18/2003
454 Life Sciences Secures $20 Million in Equity Financing to Initiate Commercialization of Whole Genome Sequencing Technology
54 Life Sciences, an innovative developer of genome-scale analysis technologies and a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), today announced that it raised $20 million from existing shareholders. - 8/21/2003
454 Life Sciences Completes First Whole Genome Sequence Using First Novel Technology Since 1977 Invention of DNA Sequencing
Complete Adenovirus sequence submitted to GenBank(R) generated by first sequencing method designed to sequence whole genomes not genes. - 8/19/2003
454 Life Sciences Obtains Exclusive License from Pyrosequencing AB to Next Generation Sequencing Technology for Whole Genome Applications
54 Life Sciences, today announced that the Company has obtained an exclusive license for sole use of sequencing by synthesis and pyrophosphate based sequencing for whole genome applications from Pyrosequencing AB (Stockholm: PYRO A). - 8/11/2003
454 Life Sciences Announces New Appointments to the Company's Scientific Advisory Board
Three leading scientists to lend their sequencing and infectious disease expertise to 454 Life Sciences as the Company's whole genome sequencing efforts accelerate - 3/11/2003
Dr. Eugene Myers Appointed to 454 Life Sciences' Scientific Advisory Board
Dr. Eugene Myers Appointed to 454 Life Sciences' Scientific Advisory Board. Former Vice President of Informatics Research at Celera Genomics To Provide Bioinformatics Guidance to 454.